API Exports From China To Rise By 30%
This article was originally published in PharmAsia News
Executive Summary
Active pharmaceutical ingredient exports from China are estimated to surge by 30% to $25 billion this year, said Xu Ming of the China Chamber of Commerce for Import & Export of Medicines & Health Products
|
Active pharmaceutical ingredient exports from China are estimated to surge by 30% to $25 billion this year, said Xu Ming of the China Chamber of Commerce for Import & Export of Medicines & Health Products. He specifically mentioned 4AA and erythromycin for international sales potential. In September, countries including India and Brazil launched investigations into China's API exports. In mid-September, China's vice environment minister stressed the need to strengthen inspections and punishment for pollution violations, which will increase environment-related costs for drug makers. (Click Here For More - Chinese Language) "API Exports Bear Positive And Negative Factors For Future"- credit-scda.net (9/ 28 /2011) |